ID: ALA388517

Max Phase: Preclinical

Molecular Formula: C14H9BrClNO4

Molecular Weight: 370.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1cccc(Br)c1)Oc1cc(Cl)ccc1C(=O)O

Standard InChI:  InChI=1S/C14H9BrClNO4/c15-8-2-1-3-10(6-8)17-14(20)21-12-7-9(16)4-5-11(12)13(18)19/h1-7H,(H,17,20)(H,18,19)

Standard InChI Key:  AQVHUBROHKHLRM-UHFFFAOYSA-N

Associated Targets(Human)

Glutamate receptor ionotropic kainate 1 340 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 370.59Molecular Weight (Monoisotopic): 368.9403AlogP: 4.41#Rotatable Bonds: 3
Polar Surface Area: 75.63Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.38CX Basic pKa: CX LogP: 4.52CX LogD: 1.11
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.84Np Likeness Score: -1.27

References

1. Valgeirsson J, Nielsen EO, Peters D, Mathiesen C, Kristensen AS, Madsen U..  (2004)  Bioisosteric modifications of 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5.,  47  (27): [PMID:15615543] [10.1021/jm030638w]

Source